Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1Gynecologic 1Gastrointestinal 1Dermatologic 1Classical hematology 1

Conditions

Tobacco Use Disorder 1Mouth Neoplasms 1Lichen Planus 1Leukokeratosis, Hereditary Mucosal 1Fanconi Anemia 1Erythroplasia 1

Interventions

pembrolizumab 77Nivolumab 64Ipilimumab 40Specimen Handling 33Magnetic Resonance Spectroscopy 27Cyclophosphamide 26Biopsy 20cemiplimab 16fludarabine 14Radiosurgery 14relatlimab 13CTLA-4 Antigen 13binimetinib 12Opdualag 12trametinib 11fludarabine phosphate 11avelumab 9Immunoglobulin G 9Blood Specimen Collection 9lifileucel 8dabrafenib 8atezolizumab 8Radiotherapy 8Disulfides 8encorafenib 7aldesleukin 7X-Rays 7Paclitaxel 7Standard of Care 6Interleukin-2 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Molecular Diagnostic Techniques × Dermatologic × 90 days × Clear all
NCT00542373 2026-03-05

Widefield Fluorescence and Reflectance Imaging Systems and Oral Tissue Samples in Monitoring Participants at Risk for Developing Oral Cancer

M.D. Anderson Cancer Center

Phase NA Active not recruiting
338 enrolled
Classical hematologyDermatologicHead & Neck

Erythroplasia, Fanconi Anemia, Lichen Planus, Mouth Neoplasms, Tobacco Use Disorder, Leukokeratosis, Hereditary Mucosal

Data powered by HemOnc (CC BY 4.0) Colophon âš¡